Marengo to Present a Late-breaking Clinical Oral Abstract at ESMO 2025 on Initial Phase 2 Clinical Data of Invikafusp Monotherapy Activity in Patients with Antigen-Rich Solid Tumors Resistant to Immune Checkpoint Blockade
Data to be presented from the STARt-001 trial demonstrating invikafusp’s single-agent anti-tumor activity in diverse, large cancer indications CAMBRIDGE, Mass., Sept. 24, 2025 /PRNewswire/ — Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation and immunology (I&I), will present a late-breaking mini oral presentation on initial Phase […]
ChainUp Wins Top Crypto Compliance Technology Honor at Thomson Reuters-Presented Awards
SINGAPORE, Sept. 24, 2025 /PRNewswire/ — ChainUp, a leading provider of B2B digital asset technology solutions, has been named Transaction Monitoring Solution Provider of the Year at the Asian Legal Business (ALB) Pan-Asian Regulatory Awards 2025, presented by Thomson Reuters. The award comes as regulators worldwide step up scrutiny of crypto transactions, underscoring the growing demand […]
First Mining Expands Newly Discovered Miroir Target with Drill Hole DUP25-064 Returning 3.23 g/t Au over 25.9 m
Near-surface drilling delivers multiple positive gold intercepts highlighted by DUP25-064, which returned 3.23 g/t Au over 25.9 m, including 11.20 g/t Au over 2.0 m, and including 10.16 g/t Au over 1.4 m, extending mineralization to 100 m depth following previously delineated 100 m strike extension First Mining continues to test and advance the Miroir target mineralization […]
Slideshare Rebrands to Inspire a New Era of Knowledge Sharing
Founded in 2006 and acquired from LinkedIn in 2020, Slideshare has long helped people discover and share presentations. This update marks its most significant evolution yet, keeping its content-first roots intact and honoring the original Slideshare identity while introducing a fresh vision for shaping ideas into opportunities. “Presentations can be daunting. We all know the […]
DeepL unveils marketplace for ready-made DeepL API solutions
Businesses can now easily discover and deploy trusted DeepL and partner apps, unlocking the full power of DeepL’s AI translation and writing APIs COLOGNE, Germany, Sept. 24, 2025 /PRNewswire/ — DeepL, a global AI product and research company, today announced the launch of DeepL Marketplace, a centralized platform where businesses can discover and deploy trusted […]
DeepL presenta su nuevo marketplace de soluciones empresariales basadas en su API
Ahora las empresas pueden descubrir y usar fácilmente las aplicaciones de DeepL y sus socios para aprovechar al máximo todo el potencial de las API de traducción y redacción con IA de DeepL. COLONIA, Alemania, 24 de septiembre de 2025 /PRNewswire/ — DeepL, una empresa internacional dedicada a la investigación y creación de productos de […]
Accelitas Launches Ai Validate | Account Ownership Validation for Real‑Time Account Ownership Validation
New solution optimizes value per transaction; opens limited, free early-access testing to the public PETALUMA, Calif., Sept. 24, 2025 /PRNewswire/ — Accelitas has introduced Ai Validate | Account Ownership Validation (AOV), the latest offering in the company’s innovative Ai Validate product line, designed for customers needing accurate and streamlined bank account ownership validation. Continue Reading Ai […]
Northstar Announces Limestone As Fourth Product Line, Supported by New Patent on Recovery Process
CALGARY, AB, Sept. 24, 2025 /PRNewswire/ – Northstar Clean Technologies Inc. (TSXV: ROOF) (OTCQB: ROOOF) (“Northstar” or the “Company“) is pleased to announce it successfully separated and recovered limestone from asphalt shingles, adding a fourth product line for the Company. Northstar has also been issued a new patent (the “Patent“) by the United States Patent […]
SystImmune, Inc. to Present New Clinical Data on Izalontamab Brengitecan and BL-M07D1 Highlighting Strength of Differentiated Antibody Drug Conjugate (ADC) Platform
REDMOND, Wash., Sept. 24, 2025 /PRNewswire/ — SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced the presentation of data on iza-bren (izalontamab brengitecan) and BL-M07D1, two distinct clinical programs from its antibody drug conjugate (ADC) pipeline, at the European Society for Medical Oncology (ESMO) Congress 2025, taking place October 17-21 in Berlin, Germany. Iza-bren, […]
Pathios Therapeutics Appoints Jon Wigginton, M.D., as Non-Executive Director
Internationally Recognized Thought Leader in Immuno-Oncology Drug Development Brings Nearly Three Decades of Clinical Oncology Experience Across Pharma, Biotech and Research Organizations OXFORD, England, Sept. 24, 2025 /PRNewswire/ — Pathios Therapeutics Limited (“Pathios”), a biotech company advancing the first clinical GPR65 antagonist program in cancer, today announced that Jon Wigginton, M.D., has been appointed as […]